Prism Medico and Pharmacy Ltd.

BSE: PRISMMEDI512217ISIN INE730E01016

Financial Services
Non Banking Financial Company (NBFC)

Share price

₹34.16-0.79 (-2.26%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹37.00
52W low: ₹15.51
Off 52W high: -7.68%
1M return: +17.87%
3M return: +23.14%
6M return: +18.82%
1Y return: +79.13%
20D avg volume: 19,932
50 DMA: ₹30.72
200 DMA: ₹27.36

Key ratios Standalone

Market cap: ₹46.33 Cr
Current price: ₹34.16
52W high / low: ₹37.00 / ₹15.51
Face value: ₹10.00
P/E: -117.79
P/B: 3.08
EPS (TTM): ₹-0.29
Book value / share: ₹11.09
ROE: -2.64%
ROCE: 2.80%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-0.06 Cr
Interest cover: —
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 1,582.6 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	0.00	0.28	0.07	0.50	1.59	0.07	0.21	0.29	0.06	—
	0.09	0.00	0.01	0.02	0.00	0.01	0.00	—	0.00	—
	0.09	0.28	0.08	0.52	1.59	0.08	0.21	0.29	0.07	—
	0.15	0.41	0.09	0.60	0.94	0.06	0.22	0.28	0.15	—
	0.00	0.22	0.04	0.45	0.86	0.01	0.15	0.24	0.05	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—
	0.02	0.03	0.01	0.01	0.01	0.01	0.01	0.01	0.01	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.13	0.16	0.04	0.13	0.07	0.04	0.06	0.03	0.09	—
	-0.06	-0.12	-0.01	-0.09	0.65	0.02	-0.01	0.01	-0.09	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—
	-0.06	-0.12	-0.01	-0.09	0.65	0.02	-0.01	0.01	-0.09	—
	0.00	0.12	0.00	0.00	-0.01	0.02	0.00	0.00	0.00	—
	-0.06	-0.24	-0.01	-0.09	0.66	0.04	-0.01	0.01	-0.09	—
	0.04	-0.30	-0.02	0.00	0.01	0.07	0.00	0.00	0.00	—
Key metrics
	-0.06	-0.12	-0.01	-0.09	0.65	0.02	-0.01	0.01	-0.09	—
	—	-42.90%	-14.30%	-18.00%	40.90%	28.60%	-4.80%	3.40%	-150.00%	—
	—	-85.70%	-14.30%	-18.00%	41.50%	57.10%	-4.80%	3.40%	-150.00%	—
	—	-0.80%	—	-0.60%	—	0.10%	—	—	—	—
	-100.00%	300.00%	-66.70%	72.40%	2,550.00%	—	—	—	—	—
	-109.10%	-700.00%	0.00%	-1,000.00%	833.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	0.85	2.44	0.63	—
	0.12	0.03	0.02	—
	0.97	2.47	0.65	—
	1.25	2.04	0.71	—
	0.71	1.57	0.45	—
	0.00	0.00	0.00	—
	0.07	0.06	0.04	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	0.46	0.40	0.22	—
	-0.28	0.43	-0.07	—
	0.00	0.00	0.00	—
	-0.28	0.43	-0.07	—
	0.12	0.11	-0.02	—
	-0.40	0.32	-0.05	—
	-0.28	0.53	-0.08	—
Key metrics
	-0.28	0.43	-0.07	—
	-32.94%	17.60%	-11.10%	—
	-47.06%	13.10%	-7.90%	—
	—	2.80%	-0.50%	—
	-60.65%	287.30%	—	—
	-157.14%	740.00%	—	—
	—	0.00	-0.02	—
	—	0.00	0.40	—
	—	0.00	0.00	—
	—	-0.06	-0.07	—
	—	1,582.6	5,996.4	—
Balance sheet
	—	15.61	15.56	—
	—	15.46	15.30	—
	—	0.06	0.07	—
	—	3.93	3.58	—
	—	6.77	6.77	—
	—	—	1.37	—
	—	0.03	0.03	—
	—	0.12	0.00	—
	—	0.20	0.47	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	15.41	15.09	—
Cash flow
	—	0.00	-0.02	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -60.65%
Profit YoY (TTM): -157.14%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 29.97%

Quarter	September 2026	June 2026
Promoter %	29.97%	29.97%

Holder	Type	Holding	Previous	Change
DHARMENDER KHARB	Public	19.35%	19.35%	0.00%
SYMBIOSIS PHARMACEUTICAL PRIVATE LIMITED	Promoter Group	15.65%	—	—
GALAXY VITACARE PRIVATE LIMITED	Promoter Group	13.25%	13.25%	0.00%
RAJU TYAGI	Public	9.77%	9.77%	0.00%
SEJAL S NASHATAR	Public	2.51%	2.51%	0.00%
RUPARELIYA SHILPA HARSH	Public	2.43%	—	—
HARSH JENTIBHAI RUPARELIYA	Public	2.43%	2.43%	0.00%
ANSHUL JAJOO	Public	1.61%	1.40%	+0.21%
EMILY BOSCO MENEZES	Public	1.11%	1.11%	0.00%
BOSCO ARMANDO MENEZES	Public	1.11%	1.11%	0.00%
RAMIT WALIA	Promoter	1.07%	1.07%	0.00%
REETA DEVI	Public	1.03%	1.03%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Bajaj Finance Limited	6,18,269	993.05	28.02	—	+18.82% TTM	+18.85% TTM	-6.05%
Shriram Finance Limited	2,13,119	905.70	16.80	—	+13.76% TTM	+28.60% TTM	+13.74%
Tata Capital Limited	1,43,392	337.80	23.16	—	—	—	+2.57%
Cholamandalam Investment and Finance Company Ltd	1,42,265	1,659.05	22.87	—	+21.13% TTM	+33.94% TTM	-5.48%
MUTHOOT FINANCE LIMITED	1,08,792	2,709.85	8.83	—	+47.27% TTM	+70.66% TTM	-15.07%
L&T Finance Limited	66,033	263.45	19.22	—	+20.11% TTM	+27.39% TTM	-5.93%
SBI CARDS AND PAYMENT SERVICES LIMITED S	52,626	553.00	20.18	—	+5.81% TTM	+35.96% TTM	-37.17%
Piramal Finance Limited	45,975	1,942.90	24.08	—	—	—	—
SUNDARAM FINANCE LTD	44,403	3,996.55	27.42	—	—	—	-16.26%
Authum Investment & Infrastructure Limited	43,913	517.10	25.16	—	-24.30% TTM	-56.50% TTM	-10.17%
HDB FINANCIAL SERVICES LIMITED S	42,098	506.65	14.22	—	—	—	-30.70%
POONAWALLA FINCORP LIMITED	41,349	469.55	38.02	—	+75.12% TTM	+399.21% TTM	-0.70%
Mahindra & Mahindra Financial Services Limited	37,542	270.05	10.42	—	+14.94% TTM	+45.99% TTM	-15.21%
Manappuram Finance Limited	29,495	314.00	20.41	—	+4.79% TTM	+85.35% TTM	+17.85%
IIFL FINANCE LIMITED	24,697	578.65	9.35	—	+35.37% TTM	+157.78% TTM	+7.38%
Capri Global Capital Limited	23,121	240.30	17.65	—	+52.88% TTM	+82.77% TTM	+21.89%
Five-Star Business Finance Ltd. S	11,724	397.15	10.50	—	+8.28% TTM	+1.05% TTM	-39.17%
SBFC Finance Limited	9,820	88.32	28.37	—	+28.23% TTM	+45.63% TTM	-24.80%
PAISALO DIGITAL LIMITED	7,279	77.43	27.42	—	+23.60% TTM	+27.97% TTM	+101.17%
Bengal & Assam Company Limited	6,477	5,680.00	8.29	—	+12.05% TTM	+3.26% TTM	-25.74%
Fedbank Financial Services Limited S	5,923	157.85	13.66	—	+21.29% TTM	+76.56% TTM	+10.46%
Mrugesh Trading Ltd. S	5,665	78.41	—	-0.30%	+21.12% TTM	+94.74% TTM	+3,464.09%
SG FINSERVE LIMITED S	4,670	708.75	24.95	—	+104.57% TTM	+86.47% TTM	+85.76%
MAS Financial Services Limited	4,607	253.90	10.89	—	+22.72% TTM	+23.77% TTM	-19.01%
Northern Arc Capital Ltd.	4,481	276.95	9.38	—	+29.02% TTM	+70.21% TTM	+0.64%
Prism Medico and Pharmacy Ltd. S	46	34.16	-117.79	2.80%	-60.65% TTM	-157.14% TTM	+79.13%

Filings & corporate actions

Recent announcements

Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve - Consider, approve ....31 Oct 2026 · Board Meeting / Board Meeting
Dear Sir/ Madam, Pursuant to Regulation 46 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached the intimation ....29 Oct 2026 · Company Update / General
Dear Sir/Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find attached the confirmation certificate ....13 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/ Madam Pursuant to Regulation 57(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), please find the ....5 Oct 2026 · Others / 57 (5) : intimation after the end of quarter
Dear Sir/ Madam, Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements), Regulations, 2015 (LODR), please find the ....30 Sep 2026 · Others / 57 (4) : Prior intimation to the beginning of the quarter
Dear Sir/Madam, Pursuant to Code of Conduct to regulate, Monitor and report Trading by Insiders (''Code'') and applicable SEBI Regulations, please find the attached intimation by the ....30 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Dear Sir/ Madam, Pursuant to Provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 and provisions of Regulation ....22 Sep 2026 · AGM/EGM / AGM
Dear Sir/Madam, Pursuant to Regulation 30(2) of SEBI (LODR) Regulations, 2015 please find the attached proceedings of the 24th Annual General Meeting of the members of the company held ....19 Sep 2026 · Company Update / General
Dear Sir/Madam, The stock exchanges are informed that the 24th Annual General Meeting of the members of the company was held on Saturday the 19th day of September, 2026 at 12:30 P.M. ....19 Sep 2026 · AGM/EGM / AGM
Dear Sir/Madam, Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith ....26 Aug 2026 · Others / Reg. 34 (1) Annual Report
Dear Sir/ Madam, Please find attached herewith intimation of Record Date for the purpose of conducting the 24th Annual General Meeting of the company to be held for the financial year ....24 Aug 2026 · Corp. Action / Record Date
Dear Sir/Madam, Please find the attached intimation of book closure for the 24th Annual General Meeting to be held for the financial year ended 31st March, 2026. You are requested ....24 Aug 2026 · Corp. Action / Book Closure
Dear Sir/ Madam, Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith ....24 Aug 2026 · Company Update / General
Dear Sir/ Madam, Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith ....24 Aug 2026 · Company Update / General
Dear Sir/Madam, The 24th Annual General Meeting of M/s. Prism Medico and Pharmacy is scheduled to be held on 19th September, 2026 through VC/OAVM. The notice of the same is attached ....24 Aug 2026 · AGM/EGM / AGM
1. Considered & approved: (i) Director''s Report for the F.Y. ended March 31, 2026 (ii) notice of 24th AGM to be held on September 19, 2026 at 12:30 P.M. through VC/OAVM 2. Fixed date ....24 Aug 2026 · Board Meeting / Outcome of Board Meeting
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2026 ,inter alia, to consider and approve ? To consider and ....19 Aug 2026 · Board Meeting / Board Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....12 Aug 2026 · Board Meeting / Outcome of Board Meeting
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone ....5 Aug 2026 · Board Meeting / Board Meeting
Dear Sir/Madam, This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India ....30 Jul 2026 · Company Update / General
Dear Sir/Madam, Please find the attache statements of investor complaints for the quarter ended 30th June, 2026. You are requested to kindly take the same on record and oblige. Thanking ....21 Jul 2026 · Company Update / General
Dear Sir/ Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find the attached certificate issued ....13 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/Madam, Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find the attached intimation for your reference and ....6 Jul 2026 · Others / 57 (5) : intimation after the end of quarter
Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), please find the attached intimation ....30 Jun 2026 · Others / 57 (4) : Prior intimation to the beginning of the quarter
Pursuant to Code of Conduct to regulate, monitor and report trading by insiders (''Code'') and applicable SEBI Regulations, please find the attached intimation letter that the trading window ....30 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....28 May 2026 · Board Meeting / Outcome of Board Meeting
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve With reference to ....23 May 2026 · Board Meeting / Board Meeting
Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors ....11 May 2026 · Others / Outcome without intimation
With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday, May 05, 2026 at the ....5 May 2026 · Company Update / Allotment of Equity Shares
With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Prism Medico and Pharmacy Limited held on Tuesday, May 05, 2026 at the ....5 May 2026 · Others / Outcome without intimation
Dear Sir/Madam, Please find the attached confirmation regarding non-applicability of large corporate entity framework. You are requested to take the same on record and oblige. Thanks ....29 Apr 2026 · Company Update / General
Dear Sir/Madam, Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find the attached certificate from the RTA for the ....21 Apr 2026 · Company Update / General
Dear Sir/Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find the attached certificate issued ....13 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/ Madam, Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find attached the intimation. Kindly take the same ....7 Apr 2026 · Others / 57 (5) : intimation after the end of quarter
Dear Sir/Madam, Pursuant to Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, please find attached the attached disclosure for your reference ....7 Apr 2026 · Company Update / General
Dear Sir/Madam, Please find the attached intimation under Regulation 57(5) of SEBI (LODR) Regulations, 2015. You are requested to kindly take the same on record and acknowledge the ....6 Apr 2026 · Others / 57 (5) : intimation after the end of quarter
Dear Sir/Madam, Please find the attached intimation under Regulation 57(4) of SEBI (LODR) Regulations, 2015. Kindly take the same on record and oblige. Thanking You.30 Mar 2026 · Company Update / General
Dear Sir/Madam, Pursuant to Code of Conduct to regulate, monitor and report Trading by Insider ("Code") and applicable SEBI Regulations, please find the attached intimation of closure ....30 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Dear Sir/Madam, Please find the attached reply to significant movement in the price of our security in the stock exchange. You are requested to take the same on record and oblige. ....30 Mar 2026 · Company Update / General
Dear Sir/Madam, Pursuant to the provisions of Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 and provision of Regulation ....24 Mar 2026 · AGM/EGM / EGM

Board meetings

5 Nov 2026 Board Meeting - Financial Results
12 Aug 2026 Board Meeting - Financial Results